Research to Improve the Care of Persons at Clinical High Risk for Psychotic Disorders (Collaborative R01) | Apply Online

Opportunity Summary:

The National Institutes of Health (NIH) funding opportunity titled "Research to Improve the Care of Persons at Clinical High Risk for Psychotic Disorders (Collaborative R01)" (Funding Opportunity Number RFA-MH-14-210) is a discretionary grant program focused on strengthening early intervention research for people who are considered at clinical high risk for developing psychotic disorders. The core idea behind the announcement is that psychotic disorders can be profoundly disabling, and that intervening earlier, before a first episode of psychosis occurs, may reduce the likelihood of progression to full psychosis while also preventing or reducing other serious downstream problems. These additional problems can include mood syndromes, substance use disorders, and major declines in everyday functioning such as school performance, work participation, and social relationships. In practical terms, the opportunity is aimed at building solid evidence that can guide how the United States identifies, treats, and supports individuals in these risk states in a more organized and staged manner.

A central theme of the announcement is the development of research that can support a stepwise, or "stepped care," approach to early psychosis intervention. Stepped care generally means matching the intensity and type of intervention to a person's needs and risk level, starting with less intensive services when appropriate and "stepping up" to more intensive or specialized interventions when clinically indicated. NIH is seeking studies that can clarify which interventions work best for which individuals, under what conditions, and through what mechanisms. The long-term goal is not only to demonstrate clinical benefit in controlled research environments, but also to create a realistic pathway for implementing these approaches in routine, community-based treatment settings where most people actually receive care.

The announcement highlights four main research aims that applicant teams are encouraged to address. First, it calls for studies that test the effectiveness of interventions designed to reduce symptoms and improve functioning among people in clinical high-risk states. Importantly, the target is not limited to preventing conversion to psychosis; it also includes improving day-to-day functioning and reducing distress and impairment that may already be present. Second, it prioritizes research that tests hypotheses about mediators and mechanisms of action, meaning investigators should go beyond asking whether an intervention works and examine why it works, what processes it changes, and how those changes translate into better clinical or functional outcomes. Third, it seeks to build an evidence base that can directly inform stepped care models for early psychosis intervention, helping decision-makers and clinicians understand how to structure services over time and how to make escalation or de-escalation decisions. Fourth, it explicitly emphasizes feasibility for implementation in community settings, encouraging designs and outcomes that speak to real-world constraints such as staffing, training, service delivery systems, and the practicality of adopting interventions outside academic specialty clinics.

From an administrative standpoint, this opportunity uses the NIH R01 research project grant mechanism and is described as a "Collaborative R01," indicating that collaborative, multi-investigator and potentially multi-site efforts are expected or strongly encouraged, especially given the complexity of early psychosis-risk research and the need for adequate sample sizes and diverse clinical settings. The program falls under the mental health research grants category (CFDA 93.242). The estimated total funding associated with this announcement is listed as $5,000,000, and it does not require cost sharing or matching funds, which reduces financial barriers for applicants who may not have access to non-federal matching resources.

Eligibility is broad and includes a wide range of public and private organizations. Eligible applicants include small businesses, other for-profit organizations, nonprofits (both 501(c)(3) and non-501(c)(3)), private and public institutions of higher education, and multiple levels of government such as state governments, county governments, city or township governments, special district governments, and independent school districts. Public housing authorities and Indian housing authorities are also listed. The eligibility section further clarifies that several institution types and community-oriented entities are eligible, including faith-based and community-based organizations, historically underrepresented and minority-serving institutions (such as HBCUs, Hispanic-serving institutions, AANAPISIs, Tribal Colleges and Universities, and Alaska Native and Native Hawaiian Serving Institutions), and tribal governments (including federally recognized and other-than-federally recognized entities). Notably, foreign organizations and foreign institutions are eligible to apply, non-U.S. components of U.S. organizations are eligible, and foreign components are allowed as defined under NIH policy, which signals openness to international collaboration when it strengthens the research.

Key dates show that the opportunity was posted and created on August 7, 2013, with an original and current closing date of January 6, 2014, and an archive date of February 6, 2014. While those dates indicate the specific announcement is no longer active, the summary still provides a clear picture of NIH priorities in this area: rigorous testing of early interventions for clinical high-risk states, careful attention to mechanisms and mediators, generation of evidence that can support stepped care decision-making, and a strong emphasis on feasibility and uptake in real-world community treatment settings. The sponsoring agency is NIH, and the full archived announcement was hosted through the NIH grants guide at the provided link.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Research to Improve the Care of Persons at Clinical High Risk for Psychotic Disorders (R01)

Previous opportunity: Human Cell Reprogramming for Functional Genetics of Alzheimers Disease (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA MH 14 210

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA MH 14 210) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 14 210", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.